RENEW BIOPHARMA INC has a total of 18 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets biotechnology, foods and drinks and environmental technology are NMC INC, BASF PLANT SCIENCE GMBH and SANFORD SCIENT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | United States | 4 | |
#4 | Canada | 2 | |
#5 | Israel | 2 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Enzymes | |
#4 | Climate change adaptation technologies | |
#5 | Fermentation | |
#6 | New plants |
# | Name | Total Patents |
---|---|---|
#1 | Botsch Kyle | 8 |
#2 | Saunders Matthew | 8 |
#3 | Mendez Michael | 7 |
#4 | Yohn Christopher | 6 |
#5 | Lanoiselee Jeremy | 5 |
#6 | Burkart Michael | 4 |
#7 | Noel Joseph | 4 |
#8 | Behnke Craig | 3 |
#9 | Poon Yan | 3 |
#10 | Gonzalez Karla | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021081246A1 | Enzyme engineering to alter the functional repertoire of cannabinoid synthases | |
WO2021067748A1 | Compositions and methods for using genetically modified orthologous enzymes | |
WO2020210810A1 | Compositions and methods for using genetically modified enzymes | |
CA3098351A1 | Enzyme engineering to alter the functional repertoire of cannabinoid synthases | |
CA3094161A1 | Compositions and methods for using genetically modified enzymes | |
US2019112617A1 | Modified rubisco large subunit proteins |